Results · Apr-Jun 2026 · filed 10 Aug 2026
Carysil Q1 FY27 results
Very strongVery strong: sales up 15% or more & profit up 25% or more on the same quarter last year, with a wider operating margin.
Sales grew 15% to ₹262 crore from ₹227 crore in Apr-Jun 2025.
Operating profit grew 22% to ₹53.4 crore, an operating margin of 20.4% (up 1.1 points from a year ago).
Net profit grew 40% to ₹32.1 crore from ₹22.9 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +12%, net profit +17%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 262.1 | 227.0 | +15% |
| Operating profit (EBITDA) | 53.4 | 43.9 | +22% |
| Operating margin | 20.4% | 19.3% | +1.1 pts |
| Net profit | 32.1 | 22.9 | +40% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Apr–Jun 2026 revenue grew 16.5% to ₹265 crore with EBITDA margin expanding 175 basis points to 21.2%. Management maintained 15% revenue guidance & 18-20% EBITDA margin guidance, tracking toward upper band, driven by domestic premiumization, export momentum & operating leverage.
The last 7 quarters
Filings that week
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 10 Aug 2026General Announcement
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.